Pharmaceutical care and medication adherence in management of psychosis in a Nigerian tertiary hospital

Pharmaceutical care and medication adherence in management of psychosis in a Nigerian tertiary hospital

Objective: The primary objective of this study is to examine the medication adherence levels (as a function of pharmaceutical care) and its contributing factors in schizophrenic patients receiving antipsychotic drugs. Methods: This was a cross-sectional study administering a structured questionnair...

Full description

Bibliographic Details
Main Authors:	Jonathan Danladi, Kakjing D Falang, Raymond A Barde, Nanlok S Jimam, Dauda A Dangiwa, Hafsat O Jimoh
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2013-01-01
Series:	Journal of Research in Pharmacy Practice
Subjects:	Antipsychotic drugs; drug adherence; pharmaceutical care; schizophrenia
Online Access:	http://www.jrpp.net/article.asp?issn=2319-9644;year=2013;volume=2;issue=2;spage=83;epage=87;aulast=Danladi

Similar Items

Predictors of poor adherence in schizophrenia
by: W. Bouali, et al.
Published: (2021-04-01)

Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis
by: Kawtar El Abdellati, et al.
Published: (2020-10-01)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
by: P. Mohr
Published: (2021-04-01)

Medication adherence in schizophrenia: The role of family supervision, dosage frequency and medication knowledge
by: Jombo HE, et al.
Published: (2015-08-01)

Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
by: Minale Tareke, et al.
Published: (2018-03-01)

Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
by: Merhawi Bahta, et al.
Published: (2021-04-01)

Drug Attitude, Insight, and Patient’s Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey
by: Nagai N, et al.
Published: (2020-03-01)

An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania
by: Jessie Mbwambo, et al.
Published: (2022-01-01)

Investigating the Effect of Adherence to Antipsychotic Therapy on the Length of Stay and Number of Hospitalizations in Patients with Schizophrenia – A Descriptive Analysis
by: Barliana MI, et al.
Published: (2023-11-01)

Correlates of poor medication adherence in chronic psychotic disorders
by: Martha Sajatovic, et al.
Published: (2021-01-01)

A randomized-controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia
by: Emmanuel eStip, et al.
Published: (2013-08-01)

Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
by: O. Vasiliu
Published: (2022-06-01)

Pharmaceutical marketing: the example of drug samples
by: Emily Couvillon Alagha, et al.
Published: (2022-12-01)

The impact of antipsychotic adherence on acute care utilization
by: Anthony J. Perkins, et al.
Published: (2023-01-01)

Modification and evaluation of tools for pharmaceutical care of patients with schizophrenia in non-psychiatric hospitals
by: Kanchana Hattasin, et al.
Published: (2018-06-01)

Unlocking the molecular mechanisms of antipsychotics – a new frontier for discovery
by: Heather Bowling, et al.
Published: (2016-07-01)

Ingestible Sensors and Medication Adherence: Focus on Use in Serious Mental Illness
by: Azita Alipour, et al.
Published: (2020-06-01)

Crossroad between current knowledge and new perspective of diagnostic and therapy of late-onset schizophrenia and very late-onset schizophrenia-like psychosis: An update
by: Olga Stȩpień-Wyrobiec, et al.
Published: (2022-10-01)

Antipsychotic medication non-adherence and factors associated among patients with schizophrenia in eastern Ethiopia
by: Fethia Mohammed, et al.
Published: (2024-02-01)

New Therapeutic Targets and Drugs for Schizophrenia Beyond Dopamine D2 Receptor Antagonists
by: Peng A, et al.
Published: (2024-03-01)

The Effect of Menopause on Antipsychotic Response
by: Alexandre González-Rodríguez, et al.
Published: (2022-10-01)

A problem of multiple drug overdose by patient with schizophrenia - case report
by: Anna Katarzyna Orzeł, et al.
Published: (2019-07-01)

Acute overdose of antipsychotics and antidepressants by patient with paranoid schizophrenia - a case report
by: Anna Katarzyna Orzeł, et al.
Published: (2019-09-01)

Current Concepts and Treatments of Schizophrenia
by: Piotr Stępnicki, et al.
Published: (2018-08-01)

Adherence to the monitoring of metabolic syndrome in patients receiving antipsychotics in outpatient clinics in Saudi Arabia
by: Feras A Al-Awad, et al.
Published: (2024-01-01)

The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study
by: Andrea Aguglia, et al.
Published: (2021-12-01)

Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021-07-01)

Clinical characteristics and treatment outcomes of patients with newly diagnosed schizophrenia: A 4‐year single‐center experience in Saudi Arabia
by: Tahir Hakami
Published: (2022-06-01)

NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality
by: Marek Krzystanek, et al.
Published: (2019-03-01)

Two Novel Loci of RELN Associated With Antipsychotics Response in Chinese Han Population
by: Qingqing Xu, et al.
Published: (2020-01-01)

Esquizofrenia: quarenta anos da hipótese dopaminérgica sob a ótica da Química Medicinal
by: Menegatti Ricardo, et al.
Published: (2004-01-01)

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
by: Adriano Aquino, et al.
Published: (2018-05-01)

Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence
by: Enrica Menditto, et al.
Published: (2020-01-01)

Alternative psychosis - Is it a defined clinical entity?
by: Girish H Banwari, et al.
Published: (2013-01-01)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
by: Davide Amato, et al.
Published: (2019-05-01)

Pharmaceutical chemical analysis : methods for identification and limit tests /
by: 328702 Pedersen, Ole
Published: (2006)

Antipsychotics use in the community of Thessaloniki, Greece
by: Papaioannidou Paraskevi, et al.
Published: (2018-01-01)

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
by: Hikaru Hori, et al.
Published: (2022-05-01)

A study of adherence and non-adherence to antipsychotic medication in patients of Schizophrenia
by: B Khar Prerna, et al.
Published: (2020-01-01)

Early Markers in Resistant Schizophrenia: Effect of the First Antipsychotic Drug
by: Georgi Panov Panov
Published: (2022-03-01)